In my opinion the main concern with the IND is about de-risking. Until we have an approved IND we can't run a trial in the US. Our original IND application was not approved, so it's obviously more than just a formality. I feel it's a significant box to have ticked and may also be viewed with enthusiasm by the market.
Once we have IND approval we wouldn't need to start a trial immediately if it didn't make sense to do so, but at least we would have passed that regulatory hurdle.
Ann: Race investor briefing invitation, page-18
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.75 |
Change
0.010(0.57%) |
Mkt cap ! $298.0M | |||
| Open | High | Low | Value | Volume |
| $1.73 | $1.83 | $1.73 | $272.0K | 152.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9998 | $1.75 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.79 | 2000 | 1 |
View Market Depth
| Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |